1-4 of 4
Roman Generalov
Close
Sort by
Journal Articles

NNV024, a Humanized Anti-CD37 Antibody with Enhanced ADCC and Extended Plasma Half-Life for the Treatment of B-Cell Malignancies

Roman Generalov, Elisa Fiorito, Stian Foss, Veronique Pascal, Helen Heyerdahl, Ada Repetto-Llamazares, Jan Terje Andersen, Geir E Tjønnfjord, Sigrid Strand Skånland, Jostein Dahle
Journal: Blood
Blood (2022) 140 (Supplement 1): 3123–3124.
https://doi.org/10.1182/blood-2022-166275
Published: 2022
Journal Articles

B-Cell Targeting Anti-CD37 Humanized Antibodies Engineered for Potent Effector Functions and Extended Plasma Half-Life

Elisa Fiorito, Roman Generalov, Stian Foss, Helen Heyerdahl, Ada Repetto-Llamazares, Veronique Pascal, Geir E Tjønnfjord, Sigrid Strand Skånland, Jan Terje Andersen, Jostein Dahle
Journal: Blood
Blood (2022) 140 (Supplement 1): 6012–6013.
https://doi.org/10.1182/blood-2022-159382
Published: 2022
Journal Articles

The Dual Cell Cycle Kinase Inhibitor JNJ-7706621 Reverses Resistance to CD37 Targeted Radioimmunotherapy in Activated B Cell like Diffuse Large B Cell Lymphoma Cell Lines

Gro Elise Rødland, PhD, Katrine Melhus, Roman Generalov, Sania Gilani, Francesco Bertoni, MD, Jostein Dahle, PhD, Randi Syljuåsen, PhD, Sebastian Patzke, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2574.
https://doi.org/10.1182/blood-2019-123287
Published: 2019
Journal Articles

Treatment with 177 lu-HH1 Increases CD20 Expression in Non-Hodgkin Lymphoma Cells in Vitro and In Vivo

Ada H.V. Repetto-Llamazares, PhD, Roy Hartvig Larsen, PhD, Landsverk Kirsti, PhD, Trond Stokke, PhD, Bergthora Eiriksdottir, PhD, Roman Generalov, MSc, Jostein Dahle, PhD
Journal: Blood
Blood (2015) 126 (23): 3245.
https://doi.org/10.1182/blood.V126.23.3245.3245
Published: 2015